scholarly article | Q13442814 |
P356 | DOI | 10.1161/CIRCOUTCOMES.111.000095 |
P50 | author | Jeffrey L. Saver | Q38328269 |
Gregg C. Fonarow | Q38543909 | ||
Lee H. Schwamm | Q40002120 | ||
Eric D. Peterson | Q63021326 | ||
P2093 | author name string | E. E. Smith | |
S. F. Ali | |||
D. L. Bhatt | |||
M. J. Reeves | |||
M. V. Grau-Sepulveda | |||
S. Messe | |||
P433 | issue | 5 | |
P921 | main subject | patient | Q181600 |
thrombolysis | Q1931577 | ||
P304 | page(s) | 543-549 | |
P577 | publication date | 2013-08-20 | |
P1433 | published in | Circulation: Cardiovascular Quality and Outcomes | Q15816436 |
P1476 | title | Temporal Trends in Patient Characteristics and Treatment With Intravenous Thrombolysis Among Acute Ischemic Stroke Patients at Get With the Guidelines-Stroke Hospitals | |
P478 | volume | 6 |
Q37662008 | Achieving best outcomes for patients with cardiovascular disease in China by enhancing the quality of medical care and establishing a learning health-care system |
Q48591320 | Co-morbid conditions in use of recombinant tissue plasminogen activator (rt-PA) for the treatment of acute ischaemic stroke |
Q36056147 | Critical early thrombolytic and endovascular reperfusion therapy for acute ischemic stroke victims: a call for adjunct neuroprotection. |
Q53359412 | Cytoprotective Drug-Tissue Plasminogen Activator Protease Interaction Assays: Screening of Two Novel Cytoprotective Chromones. |
Q47428538 | Delayed Treatment with Green Tea Polyphenol EGCG Promotes Neurogenesis After Ischemic Stroke in Adult Mice |
Q30249817 | Detecting nonvalvular atrial fibrillation and anticoagulant therapy in cardioembolic ischemic stroke |
Q50035071 | Emergency Dispatcher Stroke Recognition: Associations with Downstream Care |
Q34663418 | Enablers of the implementation of tissue plasminogen activator in acute stroke care: a cross-sectional survey |
Q37420266 | Fast neuroprotection (fast-NPRX) for acute ischemic stroke victims: the time for treatment is now. |
Q39094428 | Gender differences in neurologic emergencies part I: a consensus summary and research agenda on cerebrovascular disease |
Q22241921 | Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association |
Q26797275 | Imaging of prehospital stroke therapeutics |
Q47097232 | Implementation of stroke teams and simulation training shortened process times in a regional stroke network-A network-wide prospective trial. |
Q45074428 | In Vitro Sonothrombolysis Enhancement by Transiently Stable Microbubbles Produced by a Flow-Focusing Microfluidic Device |
Q35739435 | Intravenous Recombinant Tissue Plasminogen Activator Does Not Impact Mortality in Acute Ischemic Stroke at Any Time Point up to 6 Months: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials |
Q36577813 | Macrophage depletion reduced brain injury following middle cerebral artery occlusion in mice |
Q38763038 | Management of acute ischaemic stroke in patients with dementia |
Q38754285 | Mobile stroke units for prehospital thrombolysis, triage, and beyond: benefits and challenges. |
Q34727139 | Neurogenesis and inflammation after ischemic stroke: what is known and where we go from here |
Q26799057 | Palliative Care: A Core Competency for Stroke Neurologists |
Q38595982 | Pharmacotherapy to Enhance Cognitive and Motor Recovery Following Stroke |
Q38369639 | Prevention and management of stroke in women. |
Q35163608 | Race and sex disparities in prehospital recognition of acute stroke |
Q38702128 | Randomized trials of endovascular therapy for stroke--impact on stroke care |
Q35932824 | Should CT Angiography be a Routine Component of Acute Stroke Imaging? |
Q41168030 | Stagnation of treatment times over a decade: results of a pooled analysis from the MERCI registry, MERCI, TREVO, and TREVO 2 trials |
Q38254274 | Strategies for streamlining emergency stroke care |
Q38776049 | The High Cost of Stroke and Stroke Cytoprotection Research. |
Q48098368 | The application of nanoparticles for neuroprotection in acute ischemic stroke |
Q44776864 | Thrombolysis and clinical outcome in patients with stroke after implementation of the Tyrol Stroke Pathway: a retrospective observational study |
Q37352120 | Transthyretin provides trophic support via megalin by promoting neurite outgrowth and neuroprotection in cerebral ischemia |
Q36794959 | Why don't more patients receive intravenous rt-PA for acute stroke? |
Search more.